Table 1.
Cancer | DNA binding protein | Function | Reference |
---|---|---|---|
AML | MLL‐AEP | Immortalization of hematopoietic progenitors | 8 |
AML | AML1‐ETO | G1 cell cycle progression | 34 |
CML | Fox3a | Acquisition of resistance to imatinib | 59 |
Breast cancer | c‐Myc | Upregulation of mitotic‐associated genes | 36 |
Breast cancer | SOX2 | Induction of tamoxifen resistance | 37 |
Melanoma | DUX4 | Immune invasion through the downregulation of MHC class I | 38 |
Glioma | TRF1 | Telomeric damage and inhibition of CSC properties | 60 |
Colon | TRF2 | Induction of endothelial cell differentiation and angiogenesis | 30 |
Each DNA binding protein is associated with tumor malignancies.
AEP, AF4 family/ENL family/P‐TEFb; CSC, cancer stem cell; DUX4, double homeobox protein 4; ETO, eight‐twenty one; MLL, mixed‐lineage leukemia; SOX2, Sry‐related high‐mobility box 2; TRF1, telomere‐repeat binding factor 1.